Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

30.01.15 | Pediculosis treatment product news Jan 2015

A summary of recent pediculosis product news.

24.12.14 | Trading updates for head lice products

Two companies producing market-leading head lice products have released recent trading updates.

27.08.14 | TyraTech expands retailer base in UK

TyraTech has announced deals with further suppliers in the UK for their VaMousse head lice treatment.

24.07.14 | New Tyratech share & UK distribution deal

Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.

05.06.14 | VaMousse now available online across the US

TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.

30.01.15 | Under-reported pediculosis papers in 2014

Like the subjects of their study, coverage of academic discussions of pediculosis treatment is often incomplete. Here are three such articles from 2014 which required a second round of treatment to get hold of:

Pediculosis in Evidence-Based Dermatology

The third edition of Evidence-Based Dermatology, edited by Williams, et al. and published by John Wiley & Sons in June 2014, contains a revised chapter by Burgess & Casey on the treatment of head lice.

The chapter is a general review of the etiology of head lice and contains broad coverage of the benefits of different forms of treatment.

Egg-hatching times measured

A paper by Burgess was published in the June 2014 edition of Medical and Veterinary Entomology, giving a high-level review of the data from twenty clinical trials on how long lice eggs take to hatch.

The review found that greater than 1% of lice eggs were found to hatch at thirteen days or more after first treatment (before which it was assumed that eggs had been killed). The study therefore recommends a revised treatment regime of three doses at weekly intervals, in order to better manage this small number of late-hatching eggs.

Reviewing popular discussion of pediculosis treatments

A paper by Hine published in the July 2014 edition of the Public Understanding of Science discusses the way in which members of the public deploy scientific knowledge in discussing optimal treatments for head lice.

Focussing on interactions in online forums, the author examines how parents justify their treatment choices based on the information they have available to them.

30.01.15 | Clinical Trials Update Jan 2015

 Recent news relevant to clinical trials on pediculosis.

29.09.14 | New Review of Lice Treatments

A new critical review of head lice treatments covers the latest treatment methods and clinical trial methodology.

04.09.14 | Successful Phase 3 results for Hatchtech Xeglyze trials

Hatchtech Pty Ltd this week announced successful results for its phase 3 trials of Xeglyze™ Lotion, a novel lice and egg treatment.

27.08.14 | Clinical Trial Roundup

A summary of recent clinical trial news.

morenews-ind.png morenews-sci.png
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Licecomb Engineering
  • Scientific News
  • Regulatory News
  • Company News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved